Pan-enteric Video Capsule Endoscopy in Hereditary Haemorrhagic Telangiectasia: Gastrointestinal Manifestations and Feasibility
Endoscopy International Open · 11.08.2026 · 14 (CP)
DOI: 10.1055/a-2925-5291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 11.08.2026. Verfasst von Pernille Darre Haahr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oto-rhino-laryngologyOdense University HospitalOdenseDenmark. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aims Gastrointestinal telangiectasias are a recognised manifestation of hereditary haemorrhagic telangiectasia (HHT), but data on their nature and distribution throughout the entire gastrointestinal tract are limited. We aimed to evaluate gastrointestinal disease manifestations using pan-enteric video capsule endoscopy (VCE) and to assess its applicability in a non-selected group of patients with HHT.
Methods
In this cross-sectional study, patients aged ≥50 years with confirmed HHT residing in the Region of Southern Denmark were invited to undergo pan-enteric VCE. Telangiectatic lesions were recorded according to anatomic location and lesion burden. Feasibility outcomes included patient acceptance, completion rate, mucosal visibility and transit times. Associations between active gastrointestinal bleeding and haemoglobin concentration were analysed using multivariable linear regression.
Results
Of 52 eligible patients, 28 underwent VCE. One examination was lost due to technical failure, leaving 27 recordings available for analysis. Telangiectatic lesions were identified in 96.3% of evaluable examinations and were predominantly located in the stomach (74%) and the proximal small bowel (81.5%). Active bleeding was observed in 14.8% of patients, only in the upper gastrointestinal tract, and was independently associated with lower haemoglobin concentrations (β −2.84 g/dL, 95% CI −4.69 to −1.00; p = 0.004). Seven examinations (25.9%) were incomplete, and colonic mucosal visibility was frequently suboptimal. No capsule retention or procedure-related complications occurred.
Conclusion
Pan-enteric VCE demonstrated widespread gastrointestinal involvement in HHT, predominantly in the proximal gastrointestinal tract. Although active bleeding was infrequent, it was associated with lower haemoglobin levels. Practical limitations suggest that the role of pan-enteric VCE in routine evaluation of HHT requires further clarification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oto-rhino-laryngologyOdense University HospitalOdenseDenmark.
- Department of Medical Gastrointestinal DiseasesOdense University HospitalOdenseDenmark.
- VASCERN HHT Reference CentreOdense University HospitalOdenseRegion SyddanmarkDenmark.
- Department of CardiologyOdense University HospitalOdenseDenmark.
ORCID-Profile: Pernille Darre Haahr, Anton Bilenko, Jens Kjeldsen, Anette Drøhse Kjeldsen
Zitieren
APA
Haahr, P. D., Bilenko, A., Kjeldsen, J., Tholander, S., Poulsen, M. K., Fialla, A. D., & Kjeldsen, A. D. (2026). Pan-enteric Video Capsule Endoscopy in Hereditary Haemorrhagic Telangiectasia: Gastrointestinal Manifestations and Feasibility. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2925-5291
Vancouver
Haahr PD, Bilenko A, Kjeldsen J, Tholander S, Poulsen MK, Fialla AD, et al. Pan-enteric Video Capsule Endoscopy in Hereditary Haemorrhagic Telangiectasia: Gastrointestinal Manifestations and Feasibility. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2925-5291
BibTeX
@article{Haahr2026,
author = {Haahr, Pernille Darre and Bilenko, Anton and Kjeldsen, Jens and Tholander, Simon and Poulsen, Mikael Kjær and Fialla, Annette Dam and Kjeldsen, Anette Drøhse},
title = {Pan-enteric Video Capsule Endoscopy in Hereditary Haemorrhagic Telangiectasia: Gastrointestinal Manifestations and Feasibility},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2925-5291}
}
EUVIMED